Amarinthia Curtis | Spartanburg Regional

Dr. Amarinthia (Amy) Curtis

Claim this profile

Spartanburg Medical Center

Studies Breast Cancer
Studies Cancer
17 reported clinical trials
37 drugs studied

Area of expertise

1

Breast Cancer

Amarinthia (Amy) Curtis has run 6 trials for Breast Cancer. Some of their research focus areas include:

Stage II
Stage I
Stage III
2

Cancer

Amarinthia (Amy) Curtis has run 3 trials for Cancer. Some of their research focus areas include:

Stage I
Stage II
Stage III

Affiliated Hospitals

Image of trial facility.

Spartanburg Medical Center

Image of trial facility.

Gibbs Cancer Center-Pelham

Clinical Trials Amarinthia (Amy) Curtis is currently running

Image of trial facility.

Multiple Targeted Therapies

for Meningioma

This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.

Recruiting

1 award

Phase 2

10 criteria

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

Recruiting

1 award

Phase 2 & 3

21 criteria

More about Amarinthia (Amy) Curtis

Clinical Trial Related

8 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 6 Active Clinical Trials

Treatments Amarinthia (Amy) Curtis has experience with

  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Docetaxel
  • Paclitaxel
  • Fluorouracil
  • Gemcitabine Hydrochloride

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Amarinthia (Amy) Curtis specialize in?

Is Amarinthia (Amy) Curtis currently recruiting for clinical trials?

Are there any treatments that Amarinthia (Amy) Curtis has studied deeply?

What is the best way to schedule an appointment with Amarinthia (Amy) Curtis?

What is the office address of Amarinthia (Amy) Curtis?

Is there any support for travel costs?